C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/16 (2006.01) A61K 31/00 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 51/10 (2006.01) C07K 16/30 (2006.01) C12P 21/08 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01)
Patent
CA 2643063
The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, cytokines, interferons, target or reporter moieties and hematogenous cells.
L'invention concerne un procédé de production d'anticorps modifiant les maladies cancéreuses, dans lequel un nouveau paradigme de criblage est utilisé. Par la ségrégation des anticorps anticancéreux en faisant appel à la cytotoxicité des cellules cancéreuses comme résultat final, le procédé permet la production d'anticorps anticancéreux à des fins diagnostiques et thérapeutiques. Ces anticorps peuvent être utilisés dans la stadification et le diagnostic d'un cancer, ainsi que pour traiter des tumeurs primaires et des métastases tumorales. Lesdits anticorps anticancéreux peuvent être conjugués à des toxines, des enzymes, des composés radioactifs, des cytokines, des interférons, des fragments cibles ou rapporteurs et des cellules hématogènes.
Cechetto Lisa M.
Findlay Helen P.
Hahn Susan E.
Mcconkey Fortunata
Sayegh Daad
Arius Research Inc.
F.hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Cancerous disease modifying antibody 141205-02 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancerous disease modifying antibody 141205-02, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancerous disease modifying antibody 141205-02 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1476079